(1)
ASHISH JAIN; ABHISHEK SENGUPTA; PRIYANKA NARAD. CONSTITUTIVELY ACTIVATED TYROSINE KINASE INHIBITOR DRUG DESIGN: HOMOLOGY MODELING AND DOCKING STUDIES ON CHRONIC MYELOGENOUS LEUKEMIA BCR-ABL FUSION PROTEIN. ijpbs 2015, 6, 1215-1225.